相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Erica Jennison et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2021)
Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
Tomas Hrncir et al.
MICROORGANISMS (2021)
Resveratrol and its derivative pterostilbene ameliorate intestine injury in intrauterine growth-retarded weanling piglets by modulating redox status and gut microbiota
Yanan Chen et al.
JOURNAL OF ANIMAL SCIENCE AND BIOTECHNOLOGY (2021)
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications
Saumya Jayakumar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Reenam S. Khan et al.
HEPATOLOGY (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
Daniel Garcia et al.
CELL REPORTS (2019)
Fatty Liver Disease and Gut Microbiota: A Comprehensive Update
Lyna Campo et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2019)
Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism
Rong Ke et al.
CELL BIOLOGY INTERNATIONAL (2018)
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
Thibaut Duparc et al.
GUT (2017)
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation
David Porras et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Biological actions and molecular effects of resveratrol, pterostilbene, and 3 '-hydroxypterostilbene
Hui-Yun Tsai et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2017)
Pterostilbene ameliorates insulin sensitivity, glycemic control and oxidative stress in fructose-fed diabetic rats
Ramoji Kosuru et al.
LIFE SCIENCES (2017)
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
Daniel Garcia et al.
MOLECULAR CELL (2017)
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Hironori Kitade et al.
NUTRIENTS (2017)
Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
Chien-Chao Chiu et al.
NUTRIENTS (2017)
Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats
Wenhuan Feng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence
Ramoji Kosuru et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
The role of the gut microbiota in NAFLD
Christopher Leung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Regulation and function of AMPK in physiology and diseases
Sang-Min Jeon
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease
A. Wieland et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Inhibitory Effect of Gardenoside on Free Fatty Acid-Induced Steatosis in HepG2 Hepatocytes
Huiqing Liang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Pharmacologic Activities of 3′-Hydroxypterostilbene: Cytotoxic, Anti-Oxidant, Anti-Adipogenic, Anti-Inflammatory, Histone Deacetylase and Sirtuin 1 Inhibitory Activity
Jody K. Takemotoa et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2015)
Potent Anti-Cancer Effect of 3′-Hydroxypterostilbene in Human Colon Xenograft Tumors
Tzu-Chun Cheng et al.
PLOS ONE (2014)
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Tiphaine Le Roy et al.
GUT (2013)
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Yuki Kawano et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Hypothalamic malonyl-CoA and the control of food intake
Su Gao et al.
PHYSIOLOGY & BEHAVIOR (2013)
Pterostilbene and Cancer: Current Review
Denise McCormack et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Secondary causes of nonalcoholic fatty liver disease
Jacob M. Kneeman et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2012)
Activated AMPK inhibits PPAR-α and PPAR-γ transcriptional activity in hepatoma cells
Margaret S. Sozio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
Izet M. Kapetanovic et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function
D. Grahame Hardie
GENES & DEVELOPMENT (2011)
Up-Regulation of PPAR-γ mRNA Expression in the Liver of Obese Patients: an Additional Reinforcing Lipogenic Mechanism to SREBP-1c Induction
Paulina Pettinelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Insulin Resistance in Nonalcoholic Fatty Liver Disease
E. Bugianesi et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Pathogenesis of non-alcoholic fatty liver disease
J. K. Dowman et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Indian herbs and herbal drugs used for the treatment of diabetes
Manisha Modak et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2007)
A human hepatocellular in vitro model to investigate steatosis
Maria Jose Gomez-Lechon et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
AMP-activated protein kinase signaling in metabolic regulation
Yun Chau Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
分享论文
